New Anti-TNF Approach for Alzheimer’s Disease

A radically new approach to Alzheimer's Disease treatment is detailed in a new U.S. patent which issued today. In U.S. patent 7214658, Edward Tobinick MD, Medical Director of the Institute for Neurological Research, a private medical group, inc. in Los Angeles, describes this novel approach which attacks excess TNF-alpha, a molecule which has been called the "master regulator" of the immune response. (PRWeb May 8, 2007) Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/TG92ZS1FbXB0LUNvdXAtRW1wdC1UaGlyLVplcm8=  Read More »